Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-06

Clinical Trial Update: Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether oral magnesium can affect vascular calcification in chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nordsjaellands Hospital | Conditions: Chronic Kidney Disease, Vascular Calcification | Phase 2 | Status: COMPLETED